Literature DB >> 10747156

Evaluation of ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing.

C Riddle1, C L Lemons, M G Papich, C Altier.   

Abstract

Currently in veterinary medicine, ciprofloxacin is often used in susceptibility testing to represent the entire class of fluoroquinolone antimicrobials. Using quality control organisms as well as clinical isolates, we compared the MIC of ciprofloxacin to those of three other fluoroquinolones used in animals and found that ciprofloxacin is not an adequate representative of other members of this class.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747156      PMCID: PMC86508     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin.

Authors:  S A Marshall; R N Jones; A Wanger; J A Washington; G V Doern; A L Leber; T H Haugen
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

2.  Nalidixic acid and bacterial chromosome replication.

Authors:  G C Crumplin; J T Smith
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

3.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

  3 in total
  1 in total

1.  NCCLS quality control values for veterinary-use fluoroquinoles.

Authors:  T R Shyrock
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.